CELLINK Collaborator Enables Controlled Cell Formation
Researcher Sebastian Allig at the University of Applied Sciences Aschaffenburg used a specialized bioprinting process including Bioink from CELLINK to deposit human embryonic kidney (HEK) cells in a defined pattern. Through this research Allig found that the cells remained viable up to 8 days after printing, thus presenting a proof of concept for controlled cell formation. This is to be applied to in vitro drug screening tests in the future. CELLINK’S Bioink RGD was combined with HEK cells to print the controlled pattern to increase cell adhesion and growth. The CELLINK Cellmixer was